natgillin/translations-raw huggingface dataset:
These studies showed that rabbits that were vaccinated with Nobivac Myxo-RHD had fewer signs of myxomatosis, more antibodies against RHDV1 virus in their blood and a lower death rate than unvaccinated rabbits.
Te študije so pokazale, da so kunci, ki so bili cepljeni s cepivom Nobivac Myxo-RHD, imeli manj znakov miksomatoze, več protiteles proti virusu RHDV1 v krvi in nižjo stopnjo smrtnosti kot necepljeni kunci.
Four laboratory studies were conducted in young rabbits that showed protection began three weeks after vaccination and lasted 12 months against RHDV1 and RHDV2.
Pri mladih kuncih so bile opravljene štiri laboratorijske študije, ki so pokazale, da se je zaščita pred virusoma RHD1 in RHDV2 začela tri tedne po cepljenju in je trajala 12 mesecev.
The European Medicines Agency decided that Nobivac Myxo-RHD Plus's benefits are greater than its risks and it can be authorised for use in the EU.
Evropska agencija za zdravila je odločila, da so koristi zdravila Nobivac Myxo-RHD Plus večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
These viruses have been modified so that they also produce proteins from the outer coat of either RHDV1 (strain 009) or RHDV2 (strain MK1899).
Ti virusi so bili spremenjeni tako, da proizvajajo tudi beljakovine iz zunanje ovojnice virusov RHDV1 (sev 009) ali RHD2 (sev MK1899).
In addition, the company also presented field studies with the already authorised vaccine Nobivac Myxo-RHD which contains live myxoma vectored RHD virus strain 009 only.
Poleg tega je podjetje predstavilo terenske študije z že odobrenim cepivom Nobivac Myxo-RHD, ki vsebuje le sev 009 živega vektorskega RHD virusa miksoma.
The withdrawal period for meat from rabbits treated with Nobivac Myxo-RHD Plus is ‘zero' days, which means that there is no mandatory waiting time.
Karenca za meso kuncev, zdravljenih s cepivom Nobivac Myxo-RHD Plus, je nič dni, kar pomeni, da ni obvezne čakalne dobe.
Nobivac Myxo-RHD Plus is a vaccine.
Zdravilo Nobivac Myxo-RHD Plus je cepivo.
For more information about using Nobivac Myxo-RHD Plus, see the package leaflet or contact your veterinarian or pharmacist.
Za več informacij glede uporabe zdravila Nobivac Myxo-RHD Plus glejte navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
When a rabbit is given the vaccine, the immune system recognises the weakened viruses in the vaccine as ‘foreign' and makes antibodies against both the myxoma virus and the RHD virus proteins.
Ko kunca cepimo, imunski sistem prepozna oslabljene viruse kot tujek in začne tvoriti protitelesa proti virusu miksoma in beljakovinam virusa RHD.
Myxomatosis is caused by the myxoma virus and is spread between rabbits by close contact and biting insects such as fleas and mosquitoes.
Miksomatozo povzroča virus miksoma, širi pa se ob tesnem stiku kuncev in z ugrizi žuželk, kot so bolhe in komarji.
Nobivac Myxo-RHD Plus contains small amounts of weakened forms of the myxoma virus that causes myxomatosis.
Cepivo Nobivac MyxoRHD Plus vsebuje majhne količine oslabljenih oblik virusa miksoma, ki povzroča miksomatozo.
Nobivac Myxo-RHD Plus is a vaccine used in rabbits to reduce death and clinical signs due to myxomatosis and rabbit haemorrhagic disease (RHD).
Nobivac Myxo-RHD Plus je cepivo, ki se uporablja pri kuncih za zmanjšanje smrtnosti in kliničnih znakov miksomatoze in hemoragične bolezni kuncev (RHD).
For the full list of side effects and restrictions for Nobivac Myxo-RHD Plus, see the package leaflet.
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Nobivac Myxo-RHD Plus glejte navodilo za uporabo.
Nobivac Myxo-RHD Plus contains live myxoma vectored RHD virus strains 009 and MK1899.
Cepivo Nobivac Myxo-RHD Plus vsebuje živa vektorska seva RHD virusa miksoma 009 in MK1899.
An overview of Nobivac Myxo-RHD Plus and why it is authorised in the EU
Pregled zdravila Nobivac Myxo-RHD Plus in zakaj je odobreno v EU
Other information about Nobivac Myxo-RHD Plus
Druge informacije o zdravilu Nobivac Myxo-RHD Plus
Nobivac Myxo-RHD Plus is available as a freeze dried powder (lyophilisate) and solvent for suspension for injection and can only be obtained with a prescription.
Zdravilo Nobivac Myxo-RHD Plus je na voljo v obliki praška, posušenega z zamrzovanjem, (liofilizata) in vehikla za pripravo suspenzije za injiciranje.
Why is Nobivac Myxo-RHD Plus authorised in the EU?
Zakaj je bilo zdravilo Nobivac Myxo-RHD Plus odobreno v EU?
What is Nobivac Myxo-RHD Plus and what is it used for?
Kaj je zdravilo Nobivac Myxo-RHD Plus in za kaj se uporablja?
Nobivac Myxo-RHD Plus received a marketing authorisation valid throughout the EU on 19 November
Zdravilo Nobivac Myxo-RHD Plus je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji,
What benefits of Nobivac Myxo-RHD Plus have been shown in studies?
Kakšne koristi je zdravilo Nobivac Myxo-RHD Plus izkazalo v študijah?
What are the risks associated with Nobivac Myxo-RHD Plus?
Kakšna tveganja so povezana z zdravilom Nobivac Myxo-RHD Plus?
together with other components of the immune system, will be able to kill the viruses and help protect against the diseases.
Ko je kunec izpostavljen tem ali podobnim virusom, ta protitelesa skupaj z drugimi mehanizmi imunskega sistema uničijo virus in pripomorejo k zaščiti pred boleznijo.
How is Nobivac Myxo-RHD Plus used?
Kako se zdravilo Nobivac Myxo-RHD Plus uporablja?
How does Nobivac Myxo-RHD Plus work?
Kako zdravilo Nobivac Myxo-RHD Plus deluje?
Date of first authorisation: 15 February 2016
Datum prve odobritve: 15. februar 2016
The recommended dose is as follows:
Priporočeni odmerek je naslednji:
If not, your child may not be fully protected against the diseases.
V nasprotnem primeru vaš otrok morda ne bo popolnoma zaščiten pred boleznimi.
4.8 Undesirable effects a- Summary of the safety profile
4.8 Neželeni učinki a- Povzetek varnostnega profila
(See section 4.8).
(Glejte poglavje 4.8).
Important information about the protection provided
Pomembne informacije o zagotovljeni zaščiti
Stability data indicate that the vaccine is stable at temperatures up to 25°C for 150 hours.
Podatki o stabilnosti kažejo, da je cepivo stabilno 150 ur pri temperaturi do 25 °C.
Pack of 1 or 10.
Pakiranje po 1 ali 10.
No data are available in older children (see sections 4.8 and 5.1)
Podatki za starejše otroke niso na voljo (glejte poglavji 4.8 in 5.1)
The cough may last for one to two months or longer.
Kašelj lahko traja od enega do dveh mesecev ali dlje.
No pharmacokinetic studies have been performed.
Farmakokinetičnih študij niso izvedli.
• Temperature of 40.5°C within 48 hours, not attributable to another identifiable cause
• temperatura  40,5 °C v 48 urah, ki ji ni možno pripisati drugega prepoznavnega vzroka;
Component of a multipack.
Komponenta skupnega pakiranja.
No cases of overdose have been reported.
O primerih prevelikega odmerjanja niso poročali.
N=89 subjects from a separate study
bN=89 oseb iz ločenega preskušanja.
The coughing often has a “whooping” sound.
Kašelj ima pogosto »oslovski« zvok.
These data are intended to guide healthcare professionals in case of a temporary temperature excursion only.
Ti podatki so namenjeni kot smernica zdravstvenim delavcem le v primeru začasne spremembe temperature.
40/8/32 DU
40/8/32 D.e.
• difficulty in breathing
• težave z dihanjem;
As the benefit of vaccination is high in this group of infants, vaccination should not be withheld or delayed.
Ker je korist cepljenja v tej skupini dojenčkov velika, cepljenja ne bi smeli izpustiti ali odložiti.
There may be some circumstances, such as high incidence of pertussis, when the potential benefits outweigh possible risks.
Obstajajo okoliščine, kot je visoka incidenca oslovskega kašlja, ko potencialna korist prevlada nad možnim tveganjem.
When these signs or symptoms occur they usually develop quickly after the injection is given and while the child is still in the clinic or doctor's surgery.
Če se pojavijo ti znaki ali simptomi, se običajno razvijejo hitro po prejeti injekciji, ko je otrok še vedno v zdravstvenem domu ali v zdravnikovi ambulanti.
It can lead to paralysis or muscle weakness most commonly of the legs.
Pride lahko do paralize ali mišične oslabelosti, najpogosteje v nogah.
For instructions on handling of the medicinal product before administration, see section 6.6.
Za navodila glede ravnanja z zdravilom pred aplikacijo glejte poglavje 6.6.
At the end of this period Vaxelis should be used or discarded.
Ob koncu tega obdobja je treba cepivo Vaxelis uporabiti ali zavreči.
Other tests should be performed in order to confirm Hib infection during this period.
V tem obdobju je treba za potrditev okužbe s Hib opraviti druge preiskave.
EXP: {MM/YYYY}
EXP: {MM/LLLL}
Type 2 (MEF-1)
tipa 2 (sev MEF-1)
• The vaccine does not contain any live bacteria or viruses and it cannot cause any of the infectious diseases against which it protects.
• Cepivo ne vsebuje živih bakterij ali virusov in ne more povzročiti nalezljivih bolezni, proti katerim ščiti.
• As with any vaccine, Vaxelis may not protect 100% of children who receive the vaccine.
• Kot velja za vsa cepiva, Vaxelis morda ne bo zaščitil 100 % otrok, ki ga prejmejo.
However, a lower immune response may be observed and the level of clinical protection is unknown.
Opazili pa so, da je imunski odziv lahko slabši, raven klinične zaščite pa je neznana.
Component of a multipack, cannot be sold separately
Komponenta skupnega pakiranja, ni za ločeno prodajo.
If any of these symptoms occur after leaving the place where your child received his/her injection, you must consult a doctor IMMEDIATELY:
Če se kateri od teh simptomov pojavi, ko zapustite kraj, kjer je vaš otrok prejel injekcijo, se morate TAKOJ posvetovati z zdravnikom:
Serious allergic reactions
Hude alergijske reakcije
Do not use this vaccine after the expiry date which is stated on the carton and the label after EXP.
Tega cepiva ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki poleg oznake „EXP“.
• was born very prematurely (at or before 28 weeks of gestation).
• se je rodil veliko prezgodaj (v ali pred 28. tednom nosečnosti).
In some people, the virus can stay in the body for a long time, and can eventually lead to serious liver problems, including liver cancer.
Pri nekaterih ljudeh lahko virus ostane v telesu zelo dolgo časa in lahko privede do resnih težav z jetri, vključno z rakom na jetrih.
Vaccination with Vaxelis may need to be delayed until your child is better.
Cepljenje s cepivom Vaxelis bo morda treba preložiti, dokler se stanje vašega otroka ne izboljša.
Do not use Vaxelis if your child:
Cepiva Vaxelis ne uporabljajte, če je vaš otrok:
Immunosuppressive therapy may interfere with the development of expected immune response (see section 4.4)
Imunosupresivna terapija lahko vpliva na razvoj pričakovanega imunskega odziva (glejte poglavje 4.4).
Other medicines or vaccines and Vaxelis
Druga zdravila ali cepiva in cepivo Vaxelis
• blueness of the tongue or lips
• pomodrel jezik ali ustnice;
Results obtained for each component of the vaccine are summarised in Table 2 and Table 3.
Rezultati za posamezno komponento cepiva so povzeti v preglednici 2 in preglednici 3.
This vaccine is not intended for administration to women of child-bearing age.
Cepivo ni namenjeno dajanju ženskam v rodni dobi.
Your doctor or nurse will tell you when your child should come back for their next injection as per the local vaccination program.
Zdravnik ali medicinska sestra vam bosta povedala, kdaj se mora otrok vrniti po naslednjo injekcijo, skladno z lokalnim programom cepljenja.
Genetic Polymorphism Immune responses to the vaccine have not been studied in the context of genetic polymorphism.
Genetski polimorfizem Imunskih odzivov na cepivo v okviru genetskih polimorfizmov niso preučevali.
• Collapse or shock-like state (hypotonic-hyporesponsive episode [HHE]) within 48 hours of vaccination
• kolaps ali šoku podobno stanje (hipotonično-hiporesponzivna epizoda [HHE]) v 48 urah po cepljenju;
Pharmaco-therapeutic group: Vaccines, Bacterial and viral vaccines combined, ATC code: J07CA09
Farmakoterapevtska skupina: cepiva, kombinacije bakterijskih in virusnih cepiv, oznaka ATC: J07CA09
Limited data from 111 pre-term newborn infants in clinical trials indicate that Vaxelis can be given to premature infants.
Omejeni podatki iz 111 primerov nedonošenih novorojenčkov v kliničnih preskušanjih kažejo, da je cepivo Vaxelis mogoče dati nedonošenim dojenčkom.
• suffers from fits during a fever, or there is family history of fits occurring during a fever.
• med vročino trpi za krči ali pa obstaja družinska zdravstvena zgodovina krčev med vročino,
Serious allergic reactions are a very rare possibility (may affect up to 1 in 10,000 people) after receiving any vaccine.
Hude alergijske reakcije se pojavijo zelo redko (pri največ 1 od 10.000 cepljenih) po prejemu katerega koli cepiva.
Name and address of the manufacturers of the biological active substances Merck Sharp and Dohme Corporation 770 Sumneytown Pike
Ime in naslov izdelovalcev bioloških učinkovin Merck Sharp and Dohme Corporation 770 Sumneytown Pike
Booster dose should be given in accordance with the official recommendations.
Obnovitveni odmerek je treba dati skladno z uradnimi priporočili.
These reactions start within 24 to 72 hours after vaccination, may be associated with erythema, warmth, tenderness or pain at the injection site and resolve spontaneously within 3 to 5 days.
Te reakcije se pojavijo v 24 do 72 urah po cepljenju, lahko jih spremlja pordelost, toplota, občutljivost ali bolečina na mestu injiciranja in minejo spontano v 3 do 5 dneh.
Considerable study data suggest that individuals who have ever had a seroprotective response to hepatitis B vaccination will have a memory response that is protective against clinical disease if exposed to the hepatitis B virus.
Znatni študijski podatki kažejo, da bodo posamezniki, ki so kadar koli imeli serozaščitni odziv na cepljenje proti hepatitisu B, imeli spominski odziv, ki ščiti pred klinično boleznijo v primeru izpostavljenosti virusu hepatitisa B.
Tell your doctor or nurse if your child is taking or has recently taken or might take any other medicines or vaccines.
Obvestite zdravnika ali medicinsko sestro, če vaš otrok jemlje ali pa bo morda začel jemati katero koli drugo zdravilo ali cepivo.
To make sure that Vaxelis is suitable for your child, it is important to talk to your doctor or nurse if any of the points below apply to your child.
Da bi se prepričali, da je cepivo Vaxelis primerno za vašega otroka, je pomembno, da se pogovorite z zdravnikom ali medicinsko sestro, če kaj od spodaj navedenega velja za vašega otroka.
Your doctor or nurse will give these injections at different sites and will use different syringes and needles for each injection.
Zdravnik ali medicinska sestra bosta te injekcije uporabila na različnih mestih in bosta pri vsakem injiciranju uporabila drugo brizgo in iglo.
Adjuvants are included to improve the immune response of vaccines.
Adjuvansi so dodani za izboljšanje imunskega odziva na cepivo.
It is recommended to postpone vaccination until the end of such treatment or disease.
Priporoča se, da se cepljenje preloži na čas po koncu zdravljenja ali bolezni.
Vaccination should be preceded by a review of the individual's medical history (in particular, previous vaccinations and possible adverse reactions).
Pred cepljenjem je treba preučiti anamnezo posameznika (predvsem predhodna cepljenja in morebitne neželene učinke).
In the absence of compatibility studies, this vaccine must not be mixed with other vaccines or medicinal products.
Zaradi pomanjkanja študij kompatibilnosti cepiva ne smemo mešati z drugimi cepivi ali zdravili.
Your doctor will tell you when this dose should be given.
Zdravnik vam bo povedal, kdaj bo otrok prejel ta odmerek.
The vaccine works by causing the body to produce its own protection (antibodies) against the bacteria and viruses that cause the following diseases:
Cepivo deluje tako, da v telesu spodbudi nastajanje lastne zaščite (protiteles) proti bakterijam in virusom, ki povzročajo naslednje bolezni:
The use of Vaxelis should be in accordance with official recommendations.
Uporaba cepiva Vaxelis mora biti skladna z uradnimi priporočili.
Uncontrolled neurologic disorder or uncontrolled epilepsy: pertussis vaccination should not be administered until treatment for the condition has been established, the condition has stabilised and the benefit clearly outweighs the risk.
Nenadzorovana nevrološka bolezen ali nenadzorovana epilepsija: cepiva proti oslovskemu kašlju ne smemo dati, dokler ni uvedeno zdravljenje za to bolezen, dokler se stanje ne stabilizira in je jasno, da koristi odtehtajo tveganja.
The presence of a minor illness and /or low grade fever does not constitute a contraindication.
Prisotnost blage bolezni in/ali rahlo povišane telesne temperature ne predstavljata kontraindikacije.
Paralysis of the muscles that control breathing and swallowing can be fatal.
Paraliza mišic, ki nadzorujejo dihanje in požiranje je lahko usodna.
• allergic reaction, serious allergic reaction (anaphylactic reaction)
• alergijska reakcija, huda alergijska reakcija (anafilaktična reakcija),
• low blood pressure causing dizziness or collapse.
• nizek krvni tlak, ki povzroči omotico ali kolaps.
The needle must be fitted firmly on to the pre-filled syringe, rotating it by a one-quarter turn.
Iglo je treba trdno pritrditi na napolnjeno injekcijsko brizgo, tako da jo obrnete za četrt obrata.
However,children with long standing problems with their immune system such as HIV infection (AIDS) may still be given Vaxelis but the protection may not be as good as in children with ahealthyimmune system.
Vendar pa se otroke z dolgotrajnimi težavami zimunskim sistemom,kot jeokužbas HIV (AIDS),lahko cepi s cepivom Vaxelis, vendar zaščita morda ne bo tako dobra kot pri otrocih z zdravim imunskim sistemom.
Pack of 10 (without blue box).
Pakiranje po 10 (brez modrega okenca).
Immunocompromised children
Imunsko ogroženi otroci
Do not administer by intravascular, intradermal or subcutaneous injection.
Cepiva ne dajajte z intravaskularnim, intradermalnim ali subkutanim injiciranjem.
The immune responses to Vaxelis in these infants were generally similar to those of the overall study population.
Imunski odzivi na cepivo Vaxelis pri teh dojenčkih so v splošnem podobni kot pri celotni populaciji v preskušanju.
Nevertheless, vaccination of individuals with chronic immunodeficiency such as HIV infection is recommended even if the antibody response may be limited.
Cepljenje posameznikov s kronično imunsko pomanjkljivostjo, npr. z okužbo s HIV, je priporočeno, čeprav je odziv s protitelesi morda omejen.
• previously had Guillain-Barré syndrome (temporary loss of feeling and movement) after being given a vaccine containing tetanus toxoid (an inactivated form of tetanus toxin).
• v preteklosti imel Guillain-Barréjev sindrom (začasno nezmožnost občutenja in gibanja) po prejemu cepiva, ki je vsebovalo tetanusni toksoid (inaktivirano obliko tetanusnega toksina).
Read all of this leaflet carefully before your child is vaccinated with this medicine because it contains important information for you.
Preden je vaš otrok cepljen s tem zdravilom natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
It causes severe coughing that may lead to problems with breathing.
Povzroči hud kašelj, ki lahko privede do težav z dihanjem.
A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
A. IZDELOVALCI BIOLOŠKIH UČINKOVIN IN IZDELOVALCI, ODGOVORNI ZA SPROŠČANJE SERIJ
Your child will receive two or three injections given at least one month apart.
Vaš otrok bo prejel dve ali tri injekcije, z vsaj mesecem dni časovnega zamika.
A history of febrile convulsions, a family history of convulsions, or Sudden Infant Death Syndrome (SIDS) do not constitute a contraindication for the use of Vaxelis.
Anamneza vročinskih krčev, družinska anamneza krčev ali sindroma nenadne smrti dojenčka (SIDSSudden Infant Death Syndrome) niso kontraindikacija za uporabo cepiva Vaxelis.
Sanofi Pasteur SA 1541 Avenue Marcel Mérieux 69280 Marcy l'Etoile France
Sanofi Pasteur SA 1541 Avenue Marcel Mérieux 69280 Marcy l'Etoile Francija
•is receivinga treatment (such as steroids, chemotherapy or radiotherapy) or has a disease that suppressesor weakensthe body's ability to fight infections.
•prejema zdravljenje (kot so steroidi, kemoterapija ali obsevanje) ali ima bolezen, ki zavira ali slabi sposobnost telesa za boj proti okužbam.
• swelling of the face or throat
• otekanje obraza ali grla;
It is important to follow the instructions from the doctor or nurse so that your child completes the course of injections.
Pomembno je, da sledite navodilom zdravnika ali medicinske sestre, tako da bo vaš otrok zaključil celotno shemo cepljenja.
Lower FHA, PRN, IPV1 and IPV3 immune responses were observed after a 2-dose primary schedule (2, 4 months), although the clinical relevance of these data remain uncertain.
Nižje stopnje imunskega odziva na FHA, PRN, IPV1 in IPV3 so opazili pri programu osnovnega cepljenja z 2 odmerkoma (2., 4. mesec), vendar klinični pomen teh podatkov ostaja negotov.
Very Common Decreased appetite Uncommon Increased appetite
Presnovne in prehranske motnje zelo pogosti zmanjšan apetit občasni povečan apetit
Since the Hib capsular polysaccharide antigen is excreted in the urine, a positive urine test can be observed using sensitive tests, for at least 30 days following vaccination.
Ker se kapsularni polisaharidni antigen Hib izloča v urin, se lahko pri občutljivih testih v obdobju vsaj 30 dni po cepljenju pojavi pozitiven izvid urinskega testa.
• Diphtheria: a bacterial infection that usually first affects the throat, causing pain and swelling which can lead to suffocation.
• Davica: bakterijska okužba, ki običajno najprej prizadene grlo in ki povzroča bolečino in oteklino, ki lahko privede do zadušitve.
Poliovirus (Inactivated) Types 1/2/3
10 µg poliovirus (inaktiviran) tipa 1/2/3
• has an uncontrolled condition or severe illness affecting the brain and nervous system (uncontrolled neurologic disorder) or uncontrolled epilepsy.
• ima nenadzorovano stanje ali hudo bolezen, ki prizadene možgane in živčevje (nenadzorovano nevrološko bolezen), ali nenadzorovano epilepsijo.
Your doctor or nurse will inject Vaxelis into your child's thigh (in infants from the age of 6 weeks) or arm (in children older than one year).
Zdravnik ali medicinska sestra bosta injicirala cepivo Vaxelis v otrokovo stegno (pri dojenčkih od starosti 6 tednov) ali v roko (pri otrocih, starejših od enega leta).
The suspension should be visually inspected, prior to administration, for foreign particulate matter and/or variation of physical appearance.
Suspenzijo je potrebno pred uporabo vizualno pregledati glede tujih delcev in/ali neobičajnega fizikalnega videza.
The primary vaccination schedule consists of two or three doses, with an interval of at least 1 month between doses, and may be given from 6 weeks of age, in accordance with the official recommendations.
Program osnovnega cepljenja je sestavljen iz dveh ali treh odmerkov z vsaj 1-mesečnim premorom med odmerki in se ga lahko daje pri starosti od 6 tednov naprej skladno z uradnimi priporočili.
Anti-HBs Ag (≥ 10 IU/mL)
Protitelesa proti HBs Ag (≥ 10 i.e./ml)
• has a moderate to severe acute disease, with or without fever (e.g. sore throat, cough, cold or flu).
• ima zmerno do hudo akutno bolezen z ali brez vročine (npr. vneto grlo, kašelj, prehlad ali gripo).
Type 3 (Saukett)
tipa 3 (sev Saukett)
If your child misses a scheduled injection, it is important that you discuss with your doctor or nurse who will decide when to give the missed dose.
Če vaš otrok zamudi predvideni odmerek, je pomembno, da se pogovorite z zdravnikom ali medicinsko sestro, ki bosta določila, kdaj naj otrok prejme izpuščeni odmerek.
What is Vaxelis and what it is used for
Kaj je zdravilo Vaxelis in za kaj ga uporabljamo
Pertussis response rates were similar to the control vaccine for all pertussis antigens after the booster dose.
Stopnje odziva za oslovski kašelj so bile podobne kot pri kontrolnem cepivu za vse antigene pertusisa po obnovitvenem odmerku.
≥ 20 IU
≥ 20 i.e.